Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Hajar Abbasi-kenarsari"'
Publikováno v:
Cell Communication and Signaling, Vol 22, Iss 1, Pp 1-20 (2024)
Abstract The malignant form of melanoma is one of the deadliest human cancers that accounts for almost all of the skin tumor-related fatalities in its later stages. Achieving an exhaustive understanding of reliable cancer-specific markers and molecul
Externí odkaz:
https://doaj.org/article/47dcbabd104e4d42b952ef3ce3f55c3d
Autor:
Hamed Salehi-Lalemarzi, Dariush Shanehbandi, Farzaneh Shafaghat, Hajar Abbasi-Kenarsari, Behzad Baradaran, Ali Akbar Movassaghpour, Tohid Kazemi
Publikováno v:
Advanced Pharmaceutical Bulletin, Vol 5, Iss 2, Pp 247-253 (2015)
Purpose: PECAM-1 (CD31) is a glycoprotein expressed on endothelial and bone marrow precursor cells. It plays important roles in angiogenesis, maintenance and integration of the cytoskeleton and direction of leukocytes to the site of inflammation. W
Externí odkaz:
https://doaj.org/article/7ffda1c9382e44e698dc7dd12c69a7ea
Autor:
Farzaneh Shafaghat, Hajar Abbasi-Kenarsari, Jafar Majidi, Ali Akbar Movassaghpour, Dariush Shanehbandi, Tohid Kazemi
Publikováno v:
Advanced Pharmaceutical Bulletin, Vol 5, Iss 1, Pp 69-75 (2015)
Purpose: Transmembrane CD34 glycoprotein is the most important marker for identification, isolation and enumeration of hematopoietic stem cells (HSCs). We aimed in this study to clone the cDNA coding for human CD34 from KG1a cell line and stably expr
Externí odkaz:
https://doaj.org/article/a64af7ac786048ac9c3a020913a7e310
Autor:
Neda Heidari, Hajar Abbasi-Kenarsari, Saeed Namaki, Kaveh Baghaei, Mohammad Reza Zali, Zahra Mirsanei, Seyed Mahmoud Hashemi
Publikováno v:
Experimental cell research. 419(1)
Increasing evidence suggests that mesenchymal stem cells (MSCs) have immunosuppressive properties mediated by MSC-derived small extracellular vesicles (sEV). Exosomes are small extracellular vesicles that contain components that regulate immune cell
Autor:
Neda Heidari, Seyed Mahmoud Hashemi, Kaveh Baghaei, Mohammad Reza Zali, Hajar Abbasi-Kenarsari, Saeed Namaki, Sahar Ghaffari Khaligh
Publikováno v:
Journal of cellular physiologyREFERENCES. 236(8)
Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, is an inflammatory condition that results in gastrointestinal tract damage. Various factors, including environmental and genetic agents, disrupt the function of the i
Autor:
Neda Heidari, Hajar Abbasi-Kenarsari, Sahar Gaffari Khaligh, Abbas Shafiee, Davar Amani, Kaveh Baghaei, Mohammad Reza Zali, Seyed Mahmoud Hashemi
Publikováno v:
International immunopharmacology. 88
Cell-based therapy with tolerizing cells has been applied for the treatment of inflammatory bowel disease (IBD) in previous experimental and clinical studies with promising results. In the current study, we utilized the dextran sulfate sodium (DSS)-i
Autor:
Farzaneh Shafaghat, Dariush Shanehbandi, Tohid Kazemi, Ali Akbar Movassaghpour, Behzad Baradaran, Hamed Salehi-Lalemarzi, Hajar Abbasi-Kenarsari
Publikováno v:
Advanced Pharmaceutical Bulletin, Vol 5, Iss 2, Pp 247-253 (2015)
Purpose: PECAM-1 (CD31) is a glycoprotein expressed on endothelial and bone marrow precursor cells. It plays important roles in angiogenesis, maintenance and integration of the cytoskeleton and direction of leukocytes to the site of inflammation. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d70ddcab8497060e6328b31b450f53ff
https://europepmc.org/articles/PMC4517076/
https://europepmc.org/articles/PMC4517076/